Drug Price Competition: An 'Eye-Of-The-Beholder' Debate
This article was originally published in Scrip
Executive Summary
It was like the Pharmaceutical Research and Manufacturers of America (PhRMA) took a page straight out of the payer groups' and generic lobbyists' playbooks – declaring competition is the best way to drive down the prices of expensive medicines.